CONFIDENTIAL TREATMENT REQUESTED OPTION AGREEMENTOption Agreement • August 12th, 2015 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 12th, 2015 Company Industry JurisdictionThis Option Agreement (the “Agreement”), effective as of August 29, 2014 (the “Effective Date”), is entered by and between MabVax Therapeutics, Inc., with a principal place of business at 11588 Sorrento Valley Road, Suite 20, San Diego, CA 92121 (“MabVax”), and Juno Therapeutics, Inc., with a principal place of business at 307 Westlake Avenue North, Suite 300, Seattle, WA 98109 (“Juno”).
CONFIDENTIAL TREATMENT REQUESTED OPTION AGREEMENTOption Agreement • October 14th, 2014 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 14th, 2014 Company Industry JurisdictionThis Option Agreement (the “Agreement”), effective as of August 29, 2014 (the “Effective Date”), is entered by and between MabVax Therapeutics, Inc., with a principal place of business at 11588 Sorrento Valley Road, Suite 20, San Diego, CA 92121 (“MabVax”), and Juno Therapeutics, Inc., with a principal place of business at 307 Westlake Avenue North, Suite 300, Seattle, WA 98109 (“Juno”).